Organization
Pan Cancer T
1 abstract
Abstract
Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer.Org: Pan Cancer T, Rotterdam, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands,